Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma

DOI: 10.1080/2162402X.2019.1593802

Keywords: Carboxypeptidase 3/mutation/IL, 1β/lung cancer/urethane

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text